Small Cell Lung Carcinoma Clinical Trials
2 recruiting trials for Small Cell Lung Carcinoma. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT04938817
Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for...
This study is a rolling arm study of investigational agents as monotherapy or in combination with pembrolizumab in participants with anti-programmed cell death 1 (PD-1)/...
Sponsor: Merck Sharp & Dohme LLCEnrolling: 11020 locations
RECRUITINGPhase 1 / Phase 2NCT07155200
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Although small cell lung cancer (SCLC) responds dramatically to initial platinum-based chemotherapy, recurrences are nearly universal. The addition of atezolizumab, an immune...
Sponsor: Washington University School of MedicineEnrolling: 421 location